Hypertensi<strong>on</strong> <str<strong>on</strong>g>Medicati<strong>on</strong></str<strong>on</strong>g> <str<strong>on</strong>g>Adherence</str<strong>on</strong>g> and Productivity statistical analysis (SW, SG); provisi<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> study materials or patients (FF- T); obtaining funding (HL, FF-T); administrative, technical, or logistic support (FF-T); and supervisi<strong>on</strong> (FF-T). Address corresp<strong>on</strong>dence to: Shaloo Gupta, MS, <strong>Health</strong> Ec<strong>on</strong>omics and Outcomes Research, <strong>Kantar</strong> <strong>Health</strong>, 1 Independence Way, Ste 220, Princet<strong>on</strong>, NJ 08540. E-mail: shaloo.gupta@kantarhealth.com. REFERENCES 1. Lloyd-J<strong>on</strong>es D, Adams R, Carneth<strong>on</strong> M, et al. Heart disease and stroke statistics 2009 update: a report from the American Heart Associati<strong>on</strong> Statistics Committee and Stroke Statistics Subcommittee. Circulati<strong>on</strong>. 2009;119(e):e21-e181. 2. Chobanian A, Bakris G, Black H. The Seventh Report <str<strong>on</strong>g>of</str<strong>on</strong>g> the Joint Nati<strong>on</strong>al Committee <strong>on</strong> Preventi<strong>on</strong>, Detecti<strong>on</strong>, Evaluati<strong>on</strong>, and Treatment <str<strong>on</strong>g>of</str<strong>on</strong>g> High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572. 3. US Renal Data System, USRDS 2008 Annual Data Report: Atlas <str<strong>on</strong>g>of</str<strong>on</strong>g> Chr<strong>on</strong>ic Kidney Disease and End-Stage Renal Disease in the United States. http://www .usrds.org/atlas08.aspx. Published 2008. Accessed July 17, 2009. 4. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and c<strong>on</strong>trol <str<strong>on</strong>g>of</str<strong>on</strong>g> hypertensi<strong>on</strong> am<strong>on</strong>g United States adults 1999-2004. Hypertensi<strong>on</strong>. 2007;49(1):69-75. 5. Kannan H, Thomps<strong>on</strong> S, Bolge SC. Ec<strong>on</strong>omic and humanistic outcomes associated with comorbid type-2 diabetes, high cholesterol, and hypertensi<strong>on</strong> am<strong>on</strong>g individuals who are overweight or obese. J Occup Envir<strong>on</strong> Med. 2008;50(5): 542-549. 6. Sullivan PW, Ghushchyan V, Wyatt HR, Wu EQ, Hill JO. Productivity costs associated with cardiometabolic risk factor clusters in the United States. Value <strong>Health</strong>. 2007;10(6):443-450. 7. Bramley TJ, Gerbino PR, Nightengale BS, Frech-Tamas F. Relati<strong>on</strong>ship <str<strong>on</strong>g>of</str<strong>on</strong>g> blood pressure c<strong>on</strong>trol to adherence with antihypertensive m<strong>on</strong>otherapy in 13 managed care organizati<strong>on</strong>s. J Manag Care Pharm. 2006;12(3):239-245. 8. Elzubier AG, Husain AA, Suleiman IA, Hamid ZA. Drug compliance am<strong>on</strong>g hypertensive patients in Kassala, eastern Sudan. East Mediterr <strong>Health</strong> J. 2000; 6(1):100-105. 9. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794-811. 10. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. <str<strong>on</strong>g>Impact</str<strong>on</strong>g> <str<strong>on</strong>g>of</str<strong>on</strong>g> medicati<strong>on</strong> adherence <strong>on</strong> hospitalizati<strong>on</strong> risk and healthcare cost. Med Care. 2005;43(6): 521-530. 11. McCombs JS, Nichol MB, Newman CM, Sclar DA. The costs <str<strong>on</strong>g>of</str<strong>on</strong>g> interrupting antihypertensive drug therapy in a Medicaid populati<strong>on</strong>. Med Care. 1994;32(3): 214-226. 12. Rizzo JA, Sim<strong>on</strong>s WR. Variati<strong>on</strong>s in compliance am<strong>on</strong>g hypertensive patients by drug class: implicati<strong>on</strong>s for health care costs. Clin Ther. 1997(6);19: 1446-1457. 13. Caro JJ, Speckman JL. Existing treatment strategies: does n<strong>on</strong>compliance make a difference? J Hypertens. 1998;16(7):S31-S34. 14. C<strong>on</strong>sumer <strong>Health</strong> Sciences. Nati<strong>on</strong>al <strong>Health</strong> and Wellness Survey. http://www .chsinternati<strong>on</strong>al.com/nhws.html. Published 2008. Accessed June 16, 2009. 15. Morisky DE, Green LW, Levine DM. C<strong>on</strong>current and predictive validity <str<strong>on</strong>g>of</str<strong>on</strong>g> a selfreported measure <str<strong>on</strong>g>of</str<strong>on</strong>g> medicati<strong>on</strong> adherence. Med Care. 1986;24(1):67-74. 16. Shalansky SJ, Levy AR, Ignaszewski AP. Self-reported Morisky score for identifying n<strong>on</strong>adherence with cardiovascular medicati<strong>on</strong>s. Annals <str<strong>on</strong>g>of</str<strong>on</strong>g> Pharmacotherapy. 2004;38(9):1363-1368. 17. Kim E, Gupta S, Bolge S, Chen CC, Whitehead R, Bates JA. <str<strong>on</strong>g>Adherence</str<strong>on</strong>g> and outcomes associated with copayment burden in schizophrenia: a cross-secti<strong>on</strong>al survey. J Med Ec<strong>on</strong>. 2010;13(2):185-192. 18. Bates JA, Whitehead R, Bolge SC, Kim E. Correlates <str<strong>on</strong>g>of</str<strong>on</strong>g> medicati<strong>on</strong> adherence am<strong>on</strong>g patients with bipolar disorder: results <str<strong>on</strong>g>of</str<strong>on</strong>g> the bipolar evaluati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> satisfacti<strong>on</strong> and tolerability (BEST) study: a nati<strong>on</strong>wide cross-secti<strong>on</strong>al survey. Prim Care Compani<strong>on</strong> J Clin Psychiatry. 2010;12(5).pii:PCC.09m00883. 19. Berni A, Ciani E, Ceci<strong>on</strong>i I, Poggesi L, Abbate R, Boddi M. <str<strong>on</strong>g>Adherence</str<strong>on</strong>g> to antihypertensive therapy affects Ambulatory Arterial Stiffness Index. Eur J Intern Med. 2011;22(1):93-98. 20. George J, Munro K, McCaig DJ, Stewart DC. Prescripti<strong>on</strong> medicati<strong>on</strong>s: beliefs, experiences, behavior, and adherence <str<strong>on</strong>g>of</str<strong>on</strong>g> sheltered housing residents. Ann Pharmacother. 2006;40(12):2123-2129. 21. Berry SD, Quach L, Procter-Gray E, et al. Poor adherence to medicati<strong>on</strong>s may be associated with falls. J Ger<strong>on</strong>tol A Biol Sci Med Sci. 2010;65(5):553-558. 22. Ivanova JI, Birnbaum HG, Hsieh M, et al. <str<strong>on</strong>g>Adherence</str<strong>on</strong>g> to inhaled corticosteroid use and local adverse events in persistent asthma. Am J Manag Care. 2008; 14(12):801-809. 23. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility <str<strong>on</strong>g>of</str<strong>on</strong>g> a work productivity and activity impairment instrument. Pharmacoec<strong>on</strong>omics. 1993;4(5): 353-365. 24. Reilly MA. Reilly Associates: WPAI Scoring. http://www.reillyassociates.net/ WPAI_Scoring.html. Published 2002. Accessed July 21, 2009. 25. Pittman DG, Tao Z, Chen W, Stettin GD. Antihypertensive medicati<strong>on</strong> adherence and subsequent healthcare utilizati<strong>on</strong> and costs. Am J Manag Care. 2010; 16(8):568-576. 26. C<strong>on</strong>lin PR, Gerth WC, Fox J, Roehm JB, Boccuzzi SJ. Four-year persistence patterns am<strong>on</strong>g patients initiating therapy with the angiotensin II receptor antag<strong>on</strong>ist losartan versus other antihypertensive drug classes. Clin Ther. 2001;23(12): 1999-2010. 27. US Census Bureau. S2301. Employment Status: 2006-2008 American Community Survey 3-Year Estimates. http://factfinder2.census.gov/faces/nav/jsf/ pages/index.xhtml. Published 2008. Accessed October 20, 2010. 28. Goetzel RZ, L<strong>on</strong>g SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. <strong>Health</strong>, absence, disability, and presenteeism cost estimates <str<strong>on</strong>g>of</str<strong>on</strong>g> certain physical and mental health c<strong>on</strong>diti<strong>on</strong>s affecting U.S. employers. J Occup Envir<strong>on</strong> Med. 2004;46(4):398-412. 29. Lamb CE, Ratner PH, Johns<strong>on</strong> CE, et al. Ec<strong>on</strong>omic impact <str<strong>on</strong>g>of</str<strong>on</strong>g> workplace productivity losses due to allergic rhinitis compared with select medical c<strong>on</strong>diti<strong>on</strong>s in the United States from an employer perspective. Curr Med Res Opin. 2006;22(6): 1203-1210. 30. Rizzo JA, Abbott TA 3rd, Pashko S. Labour productivity effects <str<strong>on</strong>g>of</str<strong>on</strong>g> prescribed medicines for chr<strong>on</strong>ically ill workers. <strong>Health</strong> Ec<strong>on</strong>omics. 1996;5(3):249-226. 31. Patel BV, Remigio-Baker RA, Mehta D, Thiebaud P, Frech-Tamas F, Preblick R. Effects <str<strong>on</strong>g>of</str<strong>on</strong>g> initial antihypertensive drug class <strong>on</strong> patient persistence and compliance in a usual-care setting in the United States. J Clin Hypertens. 2007;9(9): 692-700. 32. Van Wijk BLV, Klungel OH, Heerdink ER, de Boer Ad. Rate and determinants <str<strong>on</strong>g>of</str<strong>on</strong>g> 10-year persistence with antihypertensive drugs. J Hypertens. 2005;23(11): 2101-2107. 33. Burnier M. <str<strong>on</strong>g>Medicati<strong>on</strong></str<strong>on</strong>g> adherence and persistence as the cornerst<strong>on</strong>e <str<strong>on</strong>g>of</str<strong>on</strong>g> effective antihypertensive therapy. Am J Hypertens. 2006;19(11):1190-1196. 34. Wogen J, Kreilick CA, Livornese RC, Yokoyama K, Frech F. Patient adherence with amlodipine, lisinopril, or valsartan therapy in a usual-care setting. J Manag Care Pharm. 2003;9(5):424-429. 35. Burnier M, Hess B, Greminger P, Waeber B. Determinants <str<strong>on</strong>g>of</str<strong>on</strong>g> persistence in hypertensive patients treated with irbesartan: results <str<strong>on</strong>g>of</str<strong>on</strong>g> a postmarketing survey. BMC Cardiovasc Disord. 2005;5(1):13. 36. Gregoire JP, Moisan J, Guibert R, et al. Determinants <str<strong>on</strong>g>of</str<strong>on</strong>g> disc<strong>on</strong>tinuati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> new courses <str<strong>on</strong>g>of</str<strong>on</strong>g> antihypertensive medicati<strong>on</strong>s. J Clin Epidemiol. 2002;55(7): 728-735. 37. Andrade SE, Gurwitz JH, Field TS, et al. Hypertensi<strong>on</strong> management: the care gap between clinical guidelines and clinical practice. Am J Manag Care. 2004; 10(7, pt 2):481-486. 38. Oliveria SA, Lapuerta P, McCarthy BD, L’Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management <str<strong>on</strong>g>of</str<strong>on</strong>g> unc<strong>on</strong>trolled hypertensi<strong>on</strong>. Arch Intern Med. 2002;162(4):413-420. 39. Heisler M, Hogan MM, H<str<strong>on</strong>g>of</str<strong>on</strong>g>er TP, et al. When more is not better: treatment intensificati<strong>on</strong> am<strong>on</strong>g hypertensive patients with poor medicati<strong>on</strong> adherence. Circulati<strong>on</strong>. 2008;117(22):2884-2892. 40. Burt<strong>on</strong> WN, Chen CY, Schultz AB, Edingt<strong>on</strong> DW. The prevalence <str<strong>on</strong>g>of</str<strong>on</strong>g> metabolic syndrome in an employed populati<strong>on</strong> and the impact <strong>on</strong> health and productivity. J Occup Envir<strong>on</strong> Med. 2008;50(10):1139-1148. 41. Joshi AV, Madhavan SS, Ambega<strong>on</strong>kar A, Smith M, Scott VG, Dedhia H. Associati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> medicati<strong>on</strong> adherence with workplace productivity and health-related quality <str<strong>on</strong>g>of</str<strong>on</strong>g> life in patients with asthma. J Asthma. 2006;43(7):521-526. www.ajpblive.com Vol. 4, No. 4 • The American Journal <str<strong>on</strong>g>of</str<strong>on</strong>g> Pharmacy Benefits e95
n Wagner • Lau • Frech-Tamas • Gupta 42. Burt<strong>on</strong> WN, Chen CY, C<strong>on</strong>ti DJ, Schultz AB, Edingt<strong>on</strong> DW. The associati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> antidepressant medicati<strong>on</strong> adherence with employee disability absences. Am J Manag Care. 2007;13(2):105-112. 43. Oksanen T, Kivimaki M, Pentii J, Virtanen M, Klaukka T, Vahtera J. Self-report as an indicator <str<strong>on</strong>g>of</str<strong>on</strong>g> incident disease. Ann Epidemiol. 2010;20(7):547-554. 44. Huerta JM, Tormo MJ, Egea-Caparrós JM, Ortolá-Devesa JB, Navarro C. Accuracy <str<strong>on</strong>g>of</str<strong>on</strong>g> self-reported diabetes, hypertensi<strong>on</strong> and hyperlipidemia in the adult Spanish populati<strong>on</strong>: DINO study findings [article in English, Spanish]. Rev Esp Cardiol. 2009;62(2):143-152. 45. Robins<strong>on</strong> JR, Young TK, Roos LL, Gelskey DE. Estimating the burden <str<strong>on</strong>g>of</str<strong>on</strong>g> disease: comparing administrative data and self-reports. Med Care. 1997;35(9): 932-947. 46. Tormo MJ, Navarro C, Chirlaque MD, Barber X. Validati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> self diagnosis <str<strong>on</strong>g>of</str<strong>on</strong>g> high blood pressure in a sample <str<strong>on</strong>g>of</str<strong>on</strong>g> the Spanish EPIC cohort: overall agreement and predictive values: EPIC Group <str<strong>on</strong>g>of</str<strong>on</strong>g> Spain. J Epidemiol Community <strong>Health</strong>. 2000; 54(3):221-226. 47. Al<strong>on</strong>so A, Beunza JJ, Delgado-Rodríguez M, Martínez-G<strong>on</strong>zález MA. Validati<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> self reported diagnosis <str<strong>on</strong>g>of</str<strong>on</strong>g> hypertensi<strong>on</strong> in a cohort <str<strong>on</strong>g>of</str<strong>on</strong>g> university graduates in Spain. BMC Public <strong>Health</strong>. 2005;12(5):94. 48. Ahluwalia IB, Tessaro I, Rye S, Parker L. Self-reported and clinical measurement <str<strong>on</strong>g>of</str<strong>on</strong>g> three chr<strong>on</strong>ic disease risks am<strong>on</strong>g low-income women in West Virginia. J Womens <strong>Health</strong>. 2009;18(11):1857-1862. 49. Short ME, Goetzel RZ, Pei X, et al. How accurate are self-reports? analysis <str<strong>on</strong>g>of</str<strong>on</strong>g> self-reported health care utilizati<strong>on</strong> and absence when compared with administrative data. J Occup Envir<strong>on</strong> Med. 2009;51(7):786-796. e96 The American Journal <str<strong>on</strong>g>of</str<strong>on</strong>g> Pharmacy Benefits • July/August 2012 www.ajpblive.com